Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1712 of 6351
-
Can gene activity in gastric tumors predict chemotherapy response?
Knowledge-focused Recruiting nowClinicobiological cohort of gastric cancers operated in our institution.
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New drug aims to tackle iron overload in thalassemia patients
Disease control OngoingThis study is researching an experimental drug called REGN7999 (called "study drug"). The study is focused on patients with non-transfusion dependent beta-thalassemia. The aim of the study is to see how safe and effective the study drug is. The study is looking at several other …
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Oxygen therapy could tame severe colitis Flare-Ups
Disease control By invitation onlyThe Department of Gastroenterology plans to conduct a randomized controlled study on the efficacy analysis of hyperbaric oxygen-assisted treatment for acute severe ulcerative colitis and refractory inflammatory bowel disease. The research design is a randomized, controlled study.…
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could virtual reality ease the mental toll of ICU stays?
Symptom relief OngoingAdmission to an Intensive Care Unit (ICU) is a potentially traumatic experience for a mentally vulnerable person. Beyond the stress and anxiety associated with the ICU environment and medical procedures, survivors of critical illness are at risk of developing cognitive and psycho…
Sponsor: University of the Balearic Islands • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Engineered immune cells take on stomach cancer in early trial
Disease control Recruiting nowParticipants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory at Memorial Sloan Kettering to be changed (modified) to become MSLN-targeted CAR T cells, the CAR T-cel…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could thalidomide and glutamine heal Radiation-Damaged intestines?
Disease control Recruiting nowAt present, there is still a lack of standard and effective treatment strategies and procedures for radiation intestinal injury. Studies have shown that thalidomide can effectively treat refractory gastrointestinal bleeding caused by vascular malformation. Therefore, The investig…
Phase 2 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental pill shows promise in shrinking esophageal tumors before surgery
Disease control PausedThis interventional clinical trial aims to find ways of improving treatments for individuals with esophageal cancer. Laboratory-based studies show that using medicines that affect a protein called TGF-beta (TGFβ) can kill esophageal cancer cells in individuals who have localized …
Phase 2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
A new MRI test could spot a hidden Heart-Lung danger in babies
Knowledge-focused Recruiting nowThe purpose of this study is to better understand pediatric pulmonary vein stenosis (PVS), which is the narrowing of blood vessels that connect the lungs to the heart. PVS is a life-threatening disease without a clear cause. The investigators think patients who develop PVS have a…
Phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
12-Hour eating window tested as new obesity treatment for kids
Disease control Recruiting nowThe goal of this clinical trial is to learn if time-restricted eating (TRE), an alternative method of reducing energy intake which has gained popularity in recent years, works to treat obesity in children. It will also learn about the safety and long-term adherence of 12-hour TRE…
Sponsor: Xiaoyan Shi • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Asthma care goes to school: new study tests In-School treatment to cut attacks
Disease control Recruiting nowChildren with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations. Project ASTHMA (Al…
Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI app aims to get oral cancer patients back to work
Symptom relief Recruiting nowThe goal of this clinical trial is to develop and evaluate an Artificial Intelligence Assisted Prehabilitation Program (AI APP) for returning to work and cost-effectiveness analysis in patients with oral cancer (OC). The main questions it aims to answer are: * What kinds of need…
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New study aims to close cancer care gap for indigenous americans
Knowledge-focused Recruiting nowThis clinical trial is studying the genetic changes in cells associated with different types of cancer in American Indian (AI) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. AI trib…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Can freezing kill lung cancer? new study tests cryodevitalization
Disease control OngoingThis clinical trial studies side effects and best treatment time of cryodevitalization in treating patients with early stage (stage I or stage II) lung cancer. Cryodevitalization is a type of cryosurgery that uses a flexible probe (cryoprobe) to kill tumor cells by freezing them.…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Diabetes study tests team support for better blood sugar control
Disease control By invitation onlyContinuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.
Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for Alcohol-Related liver disease: drug trial targets inflammation
Disease control Recruiting nowThe goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug TZIELD aims to delay type 1 diabetes – but is it safe long-term?
Disease control Recruiting nowStage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyperglycemia requiring eventually exogenous insulin. TZIELD® (teplizumab-mzwv) has …
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Weight loss program could open door to kidney transplants for obese patients
Disease control Recruiting nowOK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight …
Phase 4 • Sponsor: Western University, Canada • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug trial hopes to tame rare skin disease
Disease control Recruiting nowThis is a first-in-human, Phase 1/1b, 4-part study that includes the evaluation of safety, tolerability, pharmacokinetics (PK), and immunogenicity of BCX17725 when administered via single and multiple doses in healthy adult participants (Parts 1 and 2), and multiple doses in adul…
Phase 1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Radiation reduction trial aims to boost quality of life for head and neck cancer survivors
Disease control Recruiting nowTo explore the control rate and quality of life of participants with late head and neck squamous cell carcinoma who have obtained postoperative pCR after cervical lymph node surgery with neoadjuvant chemotherapy combined with immunotherapy, and the cervical lymph node removal pro…
Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug duo aims to shrink head and neck tumors
Disease control Recruiting nowThe purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Participants will receive the study drugs ACR-368 and a low dose of gemcitabine once every…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC